Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 2
2010 5
2011 3
2012 4
2013 10
2014 2
2015 3
2016 4
2017 10
2018 6
2019 9
2020 12
2021 8
2022 8
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean paola lago (57 results)?
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
Danese S, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravata I, Lavie F, Daperno M, Lukáš M, Armuzzi A, Löwenberg M, Gaya DR, Peyrin-Biroulet L; STARDUST study group. Danese S, et al. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. doi: 10.1016/S2468-1253(21)00474-X. Epub 2022 Feb 1. Lancet Gastroenterol Hepatol. 2022. PMID: 35120656 Clinical Trial.
Tofacitinib-induced eosinophilia.
Archer S, Ferreira D, Ferreira AT, Ponte S, Caetano C, Salgado M, Lago P, Pedroto I. Archer S, et al. Among authors: lago p. Rev Esp Enferm Dig. 2023 Dec;115(12):742. doi: 10.17235/reed.2023.9831/2023. Rev Esp Enferm Dig. 2023. PMID: 37539549 Free article.
Fulminant colitis.
Portela F, Lago P. Portela F, et al. Among authors: lago p. Best Pract Res Clin Gastroenterol. 2013 Oct;27(5):771-82. doi: 10.1016/j.bpg.2013.08.011. Epub 2013 Sep 6. Best Pract Res Clin Gastroenterol. 2013. PMID: 24160933 Review.
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A; QUASAR Study Group. Peyrin-Biroulet L, et al. Gastroenterology. 2023 Dec;165(6):1443-1457. doi: 10.1053/j.gastro.2023.08.038. Epub 2023 Sep 1. Gastroenterology. 2023. PMID: 37659673 Free article. Clinical Trial.
Cutaneous Crohn's disease.
Teixeira M, Machado S, Lago P, Sanches M, Selores M. Teixeira M, et al. Among authors: lago p. Int J Dermatol. 2006 Sep;45(9):1074-6. doi: 10.1111/j.1365-4632.2006.02918.x. Int J Dermatol. 2006. PMID: 16961513 No abstract available.
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study.
Magro F, Estevinho MM, Catalano G, Patita M, Arroja B, Lago P, Rosa I, Tavares de Sousa H, Ministro P, Mocanu I, Vieira A, Castela J, Moleiro J, Roseira J, Cancela E, Sousa P, Portela F, Correia L, Moreira P, Santiago M, Dias S, Afonso J, Danese S, Peyrin-Biroulet L, Dias CC; GEDII (Grupo de Estudos da Doença Inflamatória Intestinal). Magro F, et al. Among authors: lago p. United European Gastroenterol J. 2023 Jul;11(6):531-541. doi: 10.1002/ueg2.12420. Epub 2023 Jun 15. United European Gastroenterol J. 2023. PMID: 37318072 Free PMC article.
81 results